Consistent with a key role of RAS in the orchestration of drug resistance in melanoma, NF1 was the top hit in a large-scale short hairpin RNA (shRNA) screen for genes that, when lost, confer resistance to BRAF inhibition in melanoma cell lines (Whittaker et al., 2013). The gene discussed is BRAF; the disease is melanoma.